Sanaria PfSPZ Challenge With Pyrimethamine Chemoprophylaxis (PfSPZ-CVac Approach): Phase 1 Trial to Determine Safety and Protective Efficacy of Sanaria PfSPZ Challenge With Concurrent Pyrimethamine Treatment That Inhibits Development of Asexual Blood Stages of Plasmodium Falciparumc

Trial Profile

Sanaria PfSPZ Challenge With Pyrimethamine Chemoprophylaxis (PfSPZ-CVac Approach): Phase 1 Trial to Determine Safety and Protective Efficacy of Sanaria PfSPZ Challenge With Concurrent Pyrimethamine Treatment That Inhibits Development of Asexual Blood Stages of Plasmodium Falciparumc

Completed
Phase of Trial: Phase I

Latest Information Update: 10 Jun 2017

At a glance

  • Drugs Malaria vaccine live unattenuated-Sanaria (Primary) ; Chloroquine; Pyrimethamine
  • Indications Falciparum malaria
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 22 Oct 2016 Status changed from recruiting to completed.
    • 20 Oct 2015 Status changed from not yet recruiting to recruiting, according to ClinicalTrials.gov record.
    • 28 Aug 2015 Status changed from recruiting to not yet recruiting as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top